Metastatic Colorectal Cancers Recruiting Phase 1 / 2 Trials for Durvalumab (DB11714)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03202758Evaluation of the Safety and the Tolerability of Durvalumab Plus Tremelimumab Combined With FOLFOX in mCRCTreatment
NCT03376659Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic AdenocarcinomaTreatment